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Apoptosis is a tightly coordinated cell death program
that damages mitochondria, DNA, proteins, and
membrane lipids. Little is known about the fate of
RNA as cells die. Here, we show that mRNAs, but
not noncoding RNAs, are rapidly and globally
degraded during apoptosis. mRNA decay is trig-
gered early in apoptosis, preceding membrane lipid
scrambling, genomic DNA fragmentation, and
apoptotic changes to translation initiation factors.
mRNA decay depends on mitochondrial outer mem-
brane permeabilization and is amplified by caspase
activation. 30 truncated mRNA decay intermediates
with nontemplated uridylate-rich tails are generated
during apoptosis. These tails are added by the termi-
nal uridylyl transferases (TUTases) ZCCHC6 and
ZCCHC11, and the uridylated transcript intermedi-
ates are degraded by the 30 to 50 exonuclease
DIS3L2. Knockdown of DIS3L2 or the TUTases in-
hibits apoptotic mRNA decay, translation arrest,
and cell death, whereas DIS3L2 overexpression en-
hances cell death. Our results suggest that global
mRNA decay is an overlooked hallmark of apoptosis.
INTRODUCTION
Mitochondrial outer membrane permeabilization (MOMP) and
caspase activation are prominent shared events triggered by
classical apoptotic stimuli, including DNA-damaging agents,
death receptor signaling, and cytotoxic lymphocyte attack (Tay-
lor et al., 2008). MOMP releases cytochrome c from the mito-
chondrial intermembrane space into the cytosol, where it drives
the assembly of the apoptosome, the molecular scaffold that
activates caspase 9, which cleaves and activates the effector
caspase zymogens, notably caspase 3 (Riedl and Shi, 2004).
The effector caspases cleave hundreds of substrates to cause
cell death. The apoptotic program dismantles the cellular repair
machinery as the cell self-destructs. Pre-mRNA splicing andCRNA nuclear export are inhibited to prevent stress-responsive
mRNAs from being translated (Rajani et al., 2012). New protein
synthesis is blocked, ostensibly through translation initiation
factor alterations that include eIF4G cleavage and eIF2a phos-
phorylation (Holcik and Sonenberg, 2005; Morley et al., 2005;
Taylor et al., 2008). However, eiF4G cleavage is dispensable
for translation arrest (Jeffrey et al., 2002), and eIF2a phosphory-
lation and eIF4G cleavage occur after translation is inhibited
(Saelens et al., 2001). Thus, other mechanisms are needed to
explain the block in translation during apoptosis (Thomas and
Lieberman, 2013).
Human mRNAs are generally very stable, with a mean half-life
of 7 hr (Tani et al., 2012). Under normal conditions, most
mRNAs decay via deadenylation followed by decapping and
exonucleolytic decay from the 50 and 30 ends by XRN1 and the
exosome, respectively (Schoenberg and Maquat, 2012). Little
is known about what happens to RNA during apoptosis. 28S
rRNA is cleaved late in cell death (Degen et al., 2000), but not
in all dying cells. A few studies have suggested that the levels
of some mRNAs decline during cell death (Bushell et al., 2004;
Del Prete et al., 2002).
Recent work suggests that 30 uridylation might also act as a
signal for RNA turnover (Norbury, 2013). Nontemplated uridylate
residues added by terminal uridylyl transferases (TUTases) have
been found on histone mRNAs (Mullen and Marzluff, 2008; Riss-
land and Norbury, 2009; Schmidt et al., 2011; Slevin et al., 2014),
pre-miRNAs (Thornton et al., 2012), andmRNAs atmiRNA cleav-
age sites (Shen and Goodman, 2004). The TUTases ZCCHC11
(TUT4) and ZCCHC6 (TUT7) uridylate miRNAs (Thornton et al.,
2012, 2014), whereas ZCCHC11 uridylates histone mRNAs
(Schmidt et al., 2011). Human cells express three homologous
30 to 50 exoribonucleases: DIS3, DIS3L1, and DIS3L2. The first
two are primarily associated with the nuclear (DIS3) and cyto-
solic (DIS3L1) exosome, but DIS3L2 is not (Lubas et al., 2013).
DIS3L2, which preferentially degrades RNAs with 30 uridylate
residues, has been implicated in degradation of uridylated pre-
miRNAs (Chang et al., 2013; Ustianenko et al., 2013) in human
cells and mRNAs in fission yeast (Malecki et al., 2013). Knock-
down of human DIS3L2 also prolongs the half-life of mammalian
polyadenylated mRNAs (Lubas et al., 2013), suggesting that it
might also degrade mRNAs.ell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authors 1079
A B
C D
E
Figure 1. Global mRNA Decay in Apoptotic
Jurkat T Cells
(A–C) Jurkat cells were treated with aFas ± zVAD
for 4 hr, total RNA was harvested, and mRNAs (A)
and ncRNAs (B) were analyzed by qRT-PCR (UNT,
untreated) and northern blot (C). RNA expression
was normalized to U6; error bars represent the
SEM of at least three independent experiments. In
(C), 18S rRNA was visualized by ethidium bromide
staining and ActD-treated cells were included as a
control for basal RNA stability. Cell death was
confirmed by annexin V staining (C, bottom).
mRNAs declined dramatically, whereas ncRNAs
were more stable.
(D and E) Poly(A) mRNA and 18S rRNA were visu-
alized by FISH in Jurkat cells treated with aFas ±
zVAD for 3 hr; ActD was included as a control for
RNA stability. Representative images (D) and
quantification of the poly(A)/18S ratio averaged
over multiple images from four independent ex-
periments (E) are shown. Error bars represent
SEM. Scale bar, 10 mm.
*p < 0.05; **p < 0.01; ***p < 0.001, relative to
untreated (UNT). See also Figure S1.Here we show that global decay of mRNAs, but not noncoding
RNAs (ncRNAs), occurs early after induction of apoptosis
induced by diverse classical apoptotic stimuli. Decay is triggered
by MOMP and begins around the time of caspase activation and
before DNA degradation. mRNA decay intermediates are uridy-
lated near the stop codon by the TUTases ZCCHC6 and
ZCCHC11. The uridylated intermediates are further degraded
by DIS3L2. mRNA decay promotes cell death, since cells better
survive apoptotic stimuli after knockdown of DIS3L2, ZCCHC6,
or ZCCHC11. Conversely,DIS3L2 overexpression and transcrip-
tion inhibitors enhance apoptosis. These results support the
concept that global mRNA decay is a hallmark of cell death
that may amplify apoptotic signaling. Further work is required
to delineate the trigger and the complete apoptotic mRNA decay
pathway.
RESULTS
Global mRNA Decay during Apoptosis
We first measured housekeeping mRNAs and ncRNAs by quan-
titative RT-PCR (qRT-PCR) and northern blot of total RNA in
Jurkat cells treated with agonistic Fas antibody (aFas) for 4 hr
with or without the pan-caspase inhibitor z-VAD-fmk (zVAD)
(Figures 1A–1C). We found that 85% of aFas-treated cells
stained with annexin V and death was completely rescued by
zVAD (Figure 1C). qRT-PCR experiments were normalized to
U6 small nuclear RNA (snRNA), which remained relatively stable
during apoptosis. Six mRNAs, includingGAPDH andACTB (both
with reported half-lives of >12 hr; Fan et al., 2002; Tani et al.,1080 Cell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authors2012), declined by 10-fold (Figure 1A).
In contrast, some ncRNAs increased
(miR-21 and 5S rRNA) and others (U2
and 28S) declined, but much less so
than the mRNAs (Figure 1B). When thesame cells were treated with Actinomycin D (ActD) for 4 hr to
block transcription, mRNAs only declined slightly (Figure 1C),
indicating that the mRNA half-life was drastically reduced. To
test whether mRNA levels change globally during apoptosis,
we used fluorescence in situ hybridization (FISH) to probe for
18S rRNA and poly(A) mRNA (with a dT50 oligonucleotide) in Ju-
rkat cells treated with aFas ± zVAD or ActD for 3 hr (Figures 1D,
1E, and S1A). Living cells had strong poly(A) and 18S staining,
whereas apoptotic cells retained rRNA staining but lost mRNA
staining, which was rescued by zVAD. ActD had no significant
effect on the relative strength of the poly(A) and 18S signals.
To determine whether the reduction in mRNA was caused by
mRNA release into apoptotic blebs, we added aFas to Jurkat
cells in the presence of blebbistatin, a myosin II inhibitor that
blocks blebbing (Orlando et al., 2006). Blebbistatin did not inhibit
the disappearance of mRNA (Figure S1B), suggesting that
mRNA was not exported in blebs.
To test whether global mRNA decay occurs in different cell
types responding to diverse cytotoxic stimuli, we also treated
HCT116 cells with a death receptor ligand (TRAIL) and two endo-
plasmic reticulum (ER) stressors (tunicamycin and thapsigargin),
and measured apoptosis and RNA levels by annexin V staining
and qRT-PCR, respectively (Figures 2A–2C and S2A–S2F). All
treatments triggered rapid cell death and decay of mRNAs, but
not ncRNAs. To test whether this decay was global, we per-
formed FISH on HCT116 cells that were treated with TRAIL or
ActD for 2.5 hr, and on HeLa cells treated with a cytotoxic con-
centration of ActD for 6 hr (Figures 2D and 2E). In both cases,
apoptotic cells lost poly(A) mRNA signal but retained strong
A B C
D E
F G
Figure 2. Global mRNA Decay Is a Shared
Feature of Apoptosis in Diverse Cell Types
(A–C) HCT116 cells were treated with TRAIL for
4 hr. Apoptosis was measured by annexin V
staining (A), and mRNA (B) and ncRNA (C) levels
were assayed by qRT-PCR. RNA expression was
normalized to 7SL. All mRNA levels declined,
whereas ncRNAs increased or were constant. Error
bars represent the SEM of at least three inde-
pendent experiments.
(D and E) HCT116 cells treated for 2.5 hr
with TRAIL or a nontoxic concentration of ActD
(D), and HeLa cells treated for 6 hr with a cyto-
toxic concentration of ActD (E) were analyzed
by FISH. The percentage of annexin V+ cells
is shown for each condition. Images are repre-
sentative of at least three independent experi-
ments.
(F and G) CFSE-labeled YT-Indy cells were mixed
with 721.221 cells for 3 hr and stained by FISH.
Apoptosis of the target 721.221 cellswasconfirmed
by 51Cr release (data not shown). Shown is a
representative image (F) and quantification of the
poly(A)/18S ratio in nonapoptotic 721.221 cells
compared with target cells in conjugates with killer
cells over three independent experiments (G).
Poly(A) mRNA declined drastically, whereas rRNA was constant in apoptotic cells. In (D)–(F), apoptotic cells are indicated by arrowheads.
Scale bar, 10 mm. **p < 0.01; ***p < 0.001, relative to untreated (UNT) (A–C) or Living (G). See also Figure S2.rRNA staining. Cells without apoptotic nuclear morphology in the
same fields retained a strong poly(A) signal, even after complete
transcription inhibition with ActD. Global mRNA decay also
occurred in cells undergoing cytotoxic attack. Carboxyfluores-
cein succinimidyl ester (CFSE)-labeled YT-Indy natural killer cells
were incubated with 721.221 B cells for 3 hr at a ratio of 3:1 and
stained by FISH (Figures 2F and 2G). At that time, 60% of
721.221 cells were apoptotic as assessed by 51Cr release
(data not shown). Apoptotic 721.221 cells (identified by their
condensed nuclei), but not living target cells, lost mRNA signal.
The ratio of poly(A) signal to 18S signal declined significantly in
721.221 cells when they were coincubated with YT-Indy cells
(Figure 2G).
To determine whether the decay was specific for translated
RNAs, we examined the effect of staurosporine (STS) on GFP re-
porter RNAs driven by Pol I, II, or III promoters in HeLa cells. The
Pol II-driven reporters were terminated by a poly(A) sequence
(Pol II GFP), a self-cleaving hammerhead ribozyme (HR), or an
HR preceded by 60 adenylates (HR-A60) or uridylates (HR-U60)
(Figures S2G–S2J; Gaglia et al., 2012; Lee and Glaunsinger,
2009). Although all of the reporters were transcribed (Fig-
ure S2H), only Pol II GFP, HR-A60, and HR-U60 were translated
(Figures S2I and S2J). Only the translated mRNAs declined in
apoptotic cells (Figure S2H). Collectively, these results show
that mRNAs, but not ncRNAs, are degraded during apoptosis
inmultiple cell types (Jurkat, HCT116, 721.221B, andHeLa cells)
responding to different apoptotic stimuli.
mRNA Decay Occurs Early in Apoptosis and Requires
MOMP
We next determined the kinetics of the mRNA decline relative to
hallmarks of apoptosis. Jurkat cells treated with ActD ± aFasCwere harvested hourly over 4 hr and analyzed for housekeeping
gene mRNA stability by qRT-PCR, cleavage of PARP-1 and
eiF4G by immunoblot, phosphorylation of eiF2a by immunoblot,
caspase activation by a luminescent assay, annexin V binding,
and DNA fragmentation (Figures 3A–3E). ACTB and GAPDH
mRNAs began to decline within 1 hr after addition of aFas and
leveled off by 3 hr, whereas 7SL ncRNA was stable (Figure 3A).
Nonapoptotic oxidative stress caused by arsenite (+ActD) and
caspase-independent programmed cell death induced by the
killer protease granzyme A did not affect mRNA levels (Figure 3A
and data not shown). Caspase activation and PARP-1 cleavage
began at 1 hr and were complete by 3 hr (Figures 3B and 3C).
eIF2a phosphorylation and eIF4G cleavage were first detected
after 2 hr (Figure 3B). Similarly, phosphatidylserine externaliza-
tion and DNA fragmentation were not detected until 2 hr after
aFas was added (Figures 3D and 3E). Mitochondrial depolariza-
tion began within 1 hr after aFas treatment (Figure 3F). Thus,
mRNA decay occurred early in cell death coincidently with
caspase activation and mitochondrial disruption.
Because MOMP is an early step in apoptosis (Aldridge et al.,
2011), we asked whether MOMP is required for mRNA decay.
Stressors such as STS activate cell death by initiating MOMP
upstream of caspase activity, whereas aFas activates caspase
8 to trigger MOMP. Thus, zVAD blocks MOMP induced by
aFas, but not by STS (Arnoult et al., 2003; Holler et al., 2000).
We compared HeLa cells stably expressing BCL2 (HeLa-BCL2)
or an empty vector (HeLa-puro). In agreement with previous
studies (Arnoult et al., 2003), BCL2 overexpression blocked the
release of cytochrome c and effector caspase activation caused
by STS (Figure 3G). In contrast, zVAD blocked STS-triggered
caspase activation, but did not block cytochrome c release or
cell death. mRNA decay was rescued by BCL2 expression, butell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authors 1081
AB
C
D
E
F
G
H
Figure 3. mRNA Decay Begins Early in Cell
Death and Requires MOMP
(A–E) Jurkat cells were treated with ActD ± aFas or
arsenite for 4 hr and harvested hourly for qRT-PCR
(A), immunoblot (B), caspase activity by lumines-
cent assay (AU, arbitrary units) (C), annexin V
staining by flow cytometry (D), and DNA fragmen-
tation by electrophoresis (E). Asterisks in (B) indi-
cate caspase cleavage products. mRNA decay was
concurrent with caspase activation, but preceded
DNA cleavage and phosphatidylserine externaliza-
tion. Error bars represent the SEM of at least three
independent experiments. Results in (B) and (E) are
representative of multiple experiments, and the
experiment shown in (C) was performed once.
(F) Jurkat cells were treated for 1 hr with ActD ±
aFas and stained with DiIC1(5) to measure mito-
chondrial depolarization. The transmembrane
potential began dissipating within 1 hr after aFas
treatment. Results are representative of at least
three independent experiments.
(G and H) HeLa-BCL2 and HeLa-puro were treated
for 6 hr with STS ± zVAD.
(G) Fractionated cells were analyzed by immunoblot
(top) for cytochrome c release. Effector caspase
activity was measured by luminescent reporter
assay (bottom). Error bars represent the SEM of
separate wells from one experiment.
(H) RNAs were assayed by qRT-PCR. Error bars
represent the SEM of at least three independent
experiments (*p < 0.05). Results were normalized to
untreated cells. BCL2 overexpression inhibited
mRNA decay to a greater extent than did zVAD.
Survival (assayed by CytoTox-Glo assay performed
after 6 hr of STS treatment followed by a 24 hr
recovery period) was normalized to untreated cells.
See also Figure S3.only partially by zVAD (Figure 3H). Knockdown of BAX and BAK
also rescued mRNA decay to a greater extent than did zVAD
(Figure S3). Thus, mRNA decay occurs early in apoptosis and
depends on MOMP.
Depletion of Cellular mRNA Promotes Apoptosis
We hypothesized that the global mRNA depletion we observed
would contribute to apoptosis. To test the importance of main-
taining the pool of mRNAs for cell viability, we treated HeLa cells
with the Pol II inhibitor a-amanitin and examined how changes in
RNA levels over time (assessed by qRT-PCR; Figure 4A) corre-
lated with cell death (assessed by annexin V staining and flow
cytometry; Figure 4B). The decline in mRNA levels triggered by
transcription inhibition correlated closely with increased annexin
V staining (r2 = 0.98; Figure 4B). We also found that transcription
inhibition significantly enhanced the cytotoxic effect of STS,
TRAIL, and etoposide (Figure 4C). Thus, a global loss of mRNA
is incompatible with continued cell survival.
mRNA Decay Intermediates Contain Nontemplated 30
Uridylates
To begin to understand the mechanism of mRNA decay during
cell death, we searched for decay intermediates using circular
rapid amplification of cDNA ends (cRACE) (Rissland and Nor-1082 Cell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authorsbury, 2009) to ligate and amplify the 50 and 30 ends of ACTB
mRNA (Figure 5A). cRACE was performed with and without
tobacco acid pyrophosphatase (TAP) pre-treatment to distin-
guish between capped and decapped intermediates (only
decapped mRNAs can be ligated without TAP) in HeLa cells
treated with STS ± zVAD for 6 hr. Using a forward primer directed
to the ACTB 30 UTR near its polyadenylation site, we amplified
residual full-length ACTB mRNAs from both untreated and
STS-treated apoptotic cells, but only using TAP-treated RNA
(Figures S4A and S4B). There were no visible decapped decay
intermediates. The cloned and sequenced cRACE products con-
tained poly(A) tails of similar lengths independently of the treat-
ment used (Figure S4C). However, when RNA was amplified
with a PCR primer located near the stop codon in the ACTB
open reading frame (ORF), we detected decay intermediates in
apoptotic cell RNA even in cells treated with zVAD (Figure 5B).
These intermediates were also amplified without TAP pre-treat-
ment, indicating that at least some of the decay intermediates
were decapped. When the cRACE products from STS-treated
cells were cloned, the junctions that mapped exactly to the
ACTBmRNA had two notable features (Figures 5C and 5D). First,
their 30 termini were within 50 nt of the ACTB stop codon, sug-
gesting stalled decay near the ORF. Second, most junctions
captured from TAP-treated RNA had 50 termini that mapped
A B C Figure 4. Cell Viability Correlates with mRNA
Levels
(A and B) HeLa cells were treated with the
transcriptional inhibitor a-amanitin for 20 hr and
harvested at regular intervals, and RNA levels were
measuredbyqRT-PCR (A).Cell deathwasmeasured
by annexin V staining and flow cytometry, and then
plotted relative to the average level of the four
mRNAs analyzed (B). Labels on data points repre-
sent the time of a-amanitin treatment in hours. Cell
death increased as mRNA levels dropped. Results
are mean ± SEM from triplicate experiments.
(C) HeLa cells were treated with or without a-amanitin and STS, TRAIL, etoposide, or nothing (UNT) for 8 hr. Cell death was measured by annexin V staining and
flow cytometry. In all cases, transcription inhibition significantly enhanced the progression to apoptosis. Error bars represent the SEM of at least three
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.exactly to the ACTB transcription start site (TSS), whereas all of
the 50 termini captured from TAP-untreated RNA began after the
TSS. These results suggest that decay proceeds from 30 to 50 on
deadenylated mRNAs before decapping occurs. Surprisingly,
some clones had nontemplated residues between the 30 and 50
termini. These added bases were rich in uridylates (Figure 5E).
Similar results were obtained by cRACE and sequencing of
the decay intermediates of another mRNA (EEF1A; Figures
S4D–S4G). Thus, nontemplated 30 uridylates are added in the
region near the stop codon during apoptotic mRNA decay. To
confirm that 30 uridylated ACTB decay intermediates were pro-
duced during apoptosis, we performed RT-PCR on RNA isolated
from HeLa cells treated or not with STS using an A12-adaptor for
RT to prime poly(U) sequences, and nested primers targeting the
ACTB ORF and the adaptor primer (Figure 5F). Novel decay
products reproducibly appeared only in STS-treated cells (Fig-
ure 5G). Cloning and sequencing confirmed that these were
similar to the cRACE products (data not shown).
ZCCHC6 and ZCCHC11 Contribute to mRNA Decay and
Apoptosis
We hypothesized that one or more TUTases add these non-
templated uridylate-rich tails. We focused on ZCCHC6 and
ZCCHC11 because they uridylate other cytosolic RNAs (Schmidt
et al., 2011; Thornton et al., 2012, 2014). We transfected HeLa
cells with a control siRNA or siRNAs targeting ZCCHC6 and/or
ZCCHC11, or the TUTase PAPD7 (Figure 6A). Knockdown of
ZCCHC6, ZCCHC11, or both reduced apoptotic 30 uridylation
of the ACTB mRNA (Figure 6B) and partially rescued mRNA
levels after STS treatment (Figure 6C), whereas PAPD7 knock-
down had no effect. ZCCHC6 and ZCCHC11 siRNAs, alone
and in combination, reduced annexin V staining (Figure 6D)
and caspase 3 cleavage and activation (Figures 6E and 6F) in
response to STS. Again, PAPD7 siRNAs had no effect. Collec-
tively, these results suggest that ZCCHC6 and ZCCHC11 collab-
orate to uridylate mRNAs during cell death, promoting mRNA
decay and apoptosis.
DIS3L2Knockdown InhibitsmRNADecay andCell Death
Because DIS3L2 targets 30 uridylated pre-miRNAs (Chang et al.,
2013; Ustianenko et al., 2013), we hypothesized that DIS3L2
digests the uridylated mRNA decay products we observed in
cell death.We knocked downDIS3L1 (a ribonuclease in the cyto-
solic exosome, as control) and DIS3L2 in HeLa cells (Figure 7A)Cand used RT-PCR with an A12-adaptor to amplify 3
0 uridylated
ACTB mRNA intermediates (Figure 7B). Novel uridylated ACTB
products were detected in nonapoptotic cells transfected with
DIS3L2 siRNA, but not in those transfected with DIS3L1 or con-
trol siRNA. The appearance of uridylated mRNA decay interme-
diates in living cells after DIS3L2 knockdown suggests that
DIS3L2 plays a role in basal mRNA decay. After STS treatment,
the uridylated ACTBmRNA intermediates greatly increased with
DIS3L2 knockdown, and increased somewhat with DIS3L1
knockdown. We confirmed the increase in uridylated ACTB
mRNA intermediates with DIS3L2 knockdown by cloning and
sequencing cRACE products (Figures 7C and S5A–S5G). The
supplemental data in Figures S5A–S5G were obtained using
another DIS3L2 siRNA to verify that the effect of knocking
down DIS3L2 was not due to off-target effects. Knockdown of
DIS3L2, but not DIS3L1, also significantly reduced STS-medi-
atedmRNA decay of three housekeeping genes (ACTB,GAPDH,
and SDHA; Figures 7D and S5E). Knockdown of DIS3L2, but not
DIS3L1, increased the mRNA half-life in STS-treated HeLa cells
(Figures S5H and S5I). To verify that the role of DIS3L2 in mRNA
decay was not limited to STS-treated HeLa cells, we also exam-
ined DIS3L1 and DIS3L2 knockdown in HCT116 cells treated
with TRAIL (Figures S5J–S5N). DIS3L2 knockdown specifically
reduced TRAIL-mediated decay of four housekeeping genes,
but knockdown of DIS3L1 only affected one of them (and to a
lesser extent; Figure S5K). Thus, DIS3L2 is a mediator of
mRNA decay in apoptosis and may also play a role in basal
mRNA decay.
Next, we examined whether mRNA decay contributes to
apoptosis. We compared cytochrome c release, caspase activa-
tion, annexin V staining, and clonogenic survival of HeLa or
HCT116 cells transfected with control, DIS3L1, or DIS3L2
siRNAs and then treated with a variety of apoptotic stimuli.
STS-induced cytochrome c release in HeLa was reduced when
DIS3L2, but not DIS3L1, was knocked down (Figure 7E). Cas-
pase 3 cleavage was detected 4 hr after STS treatment in cells
treated with DIS3L1 or control siRNA, but was rescued by
DIS3L2 knockdown (Figure 7F). DIS3L2 knockdown also
reduced annexin V staining in HeLa cells after exposure to
STS, etoposide, tunicamycin, and several doses of TRAIL (Fig-
ures 7G and S5O). Knockdown of DIS3L1 or DIS3, the homolo-
gous exonuclease in the nuclear exosome (data not shown),
did not affect annexin V staining. Conversely, DIS3L2 overex-
pression in HeLa significantly increased annexin V staining inell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authors 1083
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Figure 5. 30 Uridylation of Apoptotic Decay
Intermediates
(A) Schematic of the cRACE method used to
identify ACTBmRNA decay intermediates. cRACE
was performed on RNA from HeLa cells treated for
6 hr with STS ± zVAD.
(B–E) ACTB decay products were amplified using
an ORF-targeted primer and a reverse primer
in the 50 UTR, and analyzed by gel electropho-
resis (B). The ACTB fragment was gel purified,
cloned, and sequenced from reactions that
were treated (D) or not (C) with TAP prior to
cRACE. Line diagrams (C and D) depict all
ORF-primer amplified cRACE clones that map-
ped to the ACTB transcript, excluding clones
with nontemplated 30 extensions. The decay in-
termediates were truncated just 30 of the stop
codon. Decapped decay intermediates (TAP)
had shortened 50 ends, whereas most clones
derived from TAP-treated RNA had a complete 50
sequence.
(E) Some apoptotic ACTB mRNA frag-
ments had nontemplated 30 tails. Shown are
nontemplated RNAs obtained from TAP-
treated RNA. Templated residues matching the
ACTB sequence are depicted as a line, and
uridylate-rich nontemplated tails are indicated.
All clones in (C)–(E) were derived from one
experiment.
(F and G) Amplification of poly(U)-tailed RNAs
using an A12-adaptor reverse RT primer.
(F) Schematic of the RT-PCR method. After RT,
nested PCR was used to amplify uridylated decay
products, with forward primers targeting the
ACTB ORF and reverse primers targeting the
adaptor sequence.
(G) Gel electrophoresis of RT-PCR products. Arrow indicates new uridylated ACTB mRNA decay fragments in apoptotic cells. The asterisk denotes
products primed from oligouridylate tracts elsewhere in the ACTB 30 UTR. Results are representative of at least three independent experiments.
See also Figure S4.response to STS, TRAIL, and tunicamycin (Figure 7H). DIS3L2
knockdown also specifically and significantly enhanced the clo-
nogenic survival of HeLa cells after TRAIL or STS treatment (Fig-
ure 7I). DIS3L2 knockdown reduced caspase activation in HeLa
cells transfected with a different siRNA (Figures S5F and S5G),
and caspase activation and cell death in HCT116 cells treated
with TRAIL (Figures S5L–S5N). Taken together, these results
show that mRNA decay, mediated by DIS3L2, strongly promotes
apoptosis.
DIS3L2-Mediated mRNA Decay Inhibits De Novo Protein
Synthesis during Apoptosis
It is well known that translation is arrested during apoptosis. This
has been attributed to post-translational modifications of trans-
lation initiation factors. However, global mRNA decay could also
have a profound effect on translation. To explore how mRNA
decay and its inhibition by DIS3L2 knockdown affect translation
during apoptosis, we measured global translation by incorpora-
tion of 35S-methionine and 35S-cysteine into HeLa cells after
control, DIS3L1, or DIS3L2 knockdown, with and without STS
treatment (Figures 7J and 7K). In the absence of STS, knock-
down of DIS3L1 or DIS3L2 did not affect translation. Following
STS treatment, translation declined by about 50% in control1084 Cell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authorscells and cells knocked down for DIS3L1. However, DIS3L2
knockdown restored translation almost to the level observed in
nonaptoptotic cells. Thus, global mRNA decay during apoptosis
strongly inhibits new protein synthesis, and inhibition of transla-
tion depends on DIS3L2.
DIS3L2 Knockdown Rescues Cell Death through MCL-1
InhibitingmRNA decay by knocking downDIS3L2 inhibited cyto-
chrome c release and caspase activation. To begin to under-
stand the mechanism behind this, we examined the effect of
DIS3L1 and DIS3L2 knockdown on pro- and antiapoptotic pro-
tein expression at baseline or after STS treatment (Figure 7L).
Although there was no discernible change in most of the proteins
examined, some of the proapoptotic proteins increased a little
after STS treatment in cells depleted of DIS3L2, including
caspases 8 and 9 and BAK. However, such changes would be
expected to enhance, rather than reduce, apoptosis. Among
the antiapoptotic proteins examined, XIAP, BCL-XL, and BCL2
did not change with DIS3L2 knockdown, but MCL-1 decreased
less after STS in DIS3L2 knockdown cells compared with
controls (Figures 7L and 7M). MCL-1, which inhibits MOMP, is
degraded by the proteasome and caspases during apoptosis
(Nijhawan et al., 2003; Weng et al., 2005). Indeed, MCL-1 levels
A B
C D
E F
Figure 6. ZCCHC6/ZCCHC11 Knockdown
Inhibits Cell Death and mRNA Decay
(A) HeLa cells were transfected with control (CTL),
ZCCHC6, and/or ZCCHC11 or PAPD7 siRNAs and
harvested 72 hr later. RNA was then analyzed by
qRT-PCR to assess knockdown.
(B) Accumulation of uridylated decay in-
termediates was assessed by RT-PCR with an
A12-adaptor primer (as in Figure 5F). Uridylated
intermediates that arose after STS treatment were
reduced after knockdown of ZCCHC6 and/or
ZCCHC11. The arrowhead denotes new prod-
ucts and the asterisk denotes products primed
from oligouridylate tracts in the ACTB 30UTR.
Results are representative of three independent
experiments.
(C–F) After knockdown and STS treatment, mRNA
levels were assayed by qRT-PCR (C). Cells were
analyzed for cell death by annexin V staining and
flow cytometry (D). Caspase activation was as-
sessed by immunoblot for caspase 3 (E) and a
luminescent caspase activity assay (F). ZCCHC6
and/or ZCCHC11 knockdown partially restored
mRNA levels, rescued cell death, and reduced
caspase 3 cleavage and activation. Error bars
represent the SEM of at least three independent
experiments.
**p < 0.01; ***p < 0.001, relative to CTL knockdown.declined substantially after STS in all cells. Degradation of its
mRNA and consequent inhibition of translation would be ex-
pected to reduce MCL-1 expression, which could promote
MOMP and downstream amplification of apoptosis. To evaluate
the interactions between DIS3L2 and BCL2L3 (the gene encod-
ing MCL-1) in apoptosis, we examined the effect on STS-medi-
ated death of knocking down BCL2L3 in HeLa cells knocked
down for DIS3L1 or DIS3L2 (Figure 7N). Rescue from death by
DIS3L2 knockdown was completely abrogated in cells that
were also knocked down for BCL2L3. This result suggests that
DIS3L2-mediated degradation of BCL2L3 mRNA contributes to
cell death in this setting.
DISCUSSION
Here, we have shown that early, global mRNA decay occurs
during classical apoptotic cell death. Global mRNA degradation,
which did not apply to ncRNA, was instigated by a variety of
proapoptotic signals (death receptor ligation, STS, etoposide,
tunicamycin, thapsigargin, high-dose ActD, and cytotoxic
attack) in several different cell types. It was specific to classical
apoptosis and did not occur during nonapoptotic oxidative
stress or caspase-independent programmed cell death trig-
gered by granzyme A. We are unaware of other physiological
settings in which mRNA is degraded so rapidly and globally.
Furthermore, global mRNA decay contributes to translation
arrest in apoptosis. Decay was inhibited by blocking MOMP
with BCL2 overexpression or BAX/BAK knockdown, but only
partially attenuated by caspase inhibition. These findings sug-Cgest that a mitochondrial product released during MOMP initi-
ates global mRNA decay. Future studies will need to define the
trigger for mRNA decay.
In this study we identified an mRNA decay pathway that
is activated during apoptosis. ACTB and EEF1A mRNA decay
intermediates had nontemplated oligouridylated 30 ends near
the stop codon. Knockdown of ZCCHC6 and ZCCHC11
TUTases reduced apoptotic 30 uridylation of mRNA decay prod-
ucts, mRNA decay, and cell death. Uridylated decay intermedi-
ates increased after DIS3L2 knockdown, which also inhibited
global mRNA decay and translation arrest. These results suggest
that the TUTases uridylate decay intermediates near the stop
codon; these are then digested by the DIS3L2 exoribonuclease,
which has specificity for uridylated 30 ends. mRNA decay can
occur on translating polyribosomes (Hu et al., 2009, 2010; Lubas
et al., 2013; Slevin et al., 2014). Uridylation of stalled transcripts
and DIS3L2 digestion of uridylated mRNAs may serve to reiniti-
ate degradation caused by stalling at ribosomes.
The TUTases and DIS3L2 are likely responsible for only some
of the steps of apoptotic mRNA decay. We did not find that
poly(A) tails of ACTB mRNAs were 30 uridylated (Figures S4A–
S4C), suggesting that mRNAs may be deadenylated prior to
uridylation. Recent work indicates that mRNAs frequently have
uridylate residues at the end of their poly(A) tail in nonapoptotic
cells (Chang et al., 2014). It may be that full-length mRNAs are
uridylated and then rapidly degraded by DIS3L2. Alternatively,
another 30 to 50 exoribonuclease or endonuclease might digest
deadenylated or polyadenylated mRNAs to initiate the decay
pathway. Other candidate nucleases are the exosome, ERI1,ell Reports 11, 1079–1089, May 19, 2015 ª2015 The Authors 1085
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Figure 7. DIS3L2 Knockdown in HeLa Cells Inhibits Cell Death and mRNA Decay
(A) HeLa cells transfected with control (CTL), DIS3L1, or DIS3L2 siRNAs were harvested 72 hr later for immunoblot, confirming robust knockdown of DIS3L1 and
DIS3L2 proteins.
(B) Accumulation of uridylated decay intermediates was assessed by RT-PCRwith an A12-adaptor primer (as in Figure 5F). Uridylated intermediates accumulated
in STS-treated cells regardless of the siRNA transfected, but accumulated to a greater extent after DIS3L2 knockdown. The arrowhead denotes new products
and the asterisk denotes products primed from oligouridylate tracts in the ACTB 30 UTR. Results are representative of at least three independent experiments.
(C) Increased uridylation was validated by cloning cRACE products (as in Figure 5). For knockdown in this experiment and Figures S5A–S5G, we used an
independent set of siRNAs to verify that the results were not due to off-target effects of gene knockdown. Products with two or more nontemplated uridylates
were more abundant in STS-treated cells after DIS3L2 knockdown, but the proportion of products with any nontemplated residues on the 30 end was similar
between the CTL and DIS3L2 knockdown samples.
(D–F) After knockdown and STS treatment, mRNA levels were assayed by qRT-PCR (D). Cytochrome c releasewasmeasured by cellular fractionation followed by
immunoblot (E) and caspase 3 cleavage was measured by immunoblot (F). b-Actin (ACTB) was probed as a loading control and VDAC1 was probed to verify
fractionation. DIS3L2 knockdown partially restored mRNA levels and reduced cytochrome c release and caspase 3 cleavage.
(legend continued on next page)
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and deadenylases (Hoefig et al., 2013; Schoenberg andMaquat,
2012). Knockdown of deadenylases and the exosome subunit
EXOSC10 yielded inconsistent results in preliminary studies.
Their potential role in initiating apoptotic mRNA decay merits
further investigation. Knockdown of the ER stress-induced
endonuclease IRE1 (Hollien andWeissman, 2006), unlike knock-
down of ZCCHC6, ZCCHC11, and DIS3L2, promoted cell death
(data not shown), making it unlikely that this nuclease is respon-
sible for apoptotic mRNA decay.
We previously found that mRNA splicing and RNA export were
disabled during both classical apoptosis and caspase-indepen-
dent programmed cell death (Rajani et al., 2012). The resulting
impaired translation of mRNAs induced in response to death
stimuli promoted apoptosis by interfering with new protein
synthesis needed for cellular repair. Nowwe find that preexisting
mRNAs are rapidly degraded during classical apoptosis.
Althoughwe observed a stark reduction in poly(A) mRNAs during
apoptosis, it is possible that somemRNAs are resistant to decay
because of their subcellular localization or other features (such
as structure). Deep sequencing of cellular RNAs in cells undergo-
ing apoptosis could help to further delineate the apoptotic
mRNA decay pathway.
Our results indicate that global apoptotic mRNA degradation
arrests new protein synthesis, which is restored by knocking
down DIS3L2 (Figures 7J and 7K). mRNA decay occurs before
alterations to translation initiation factors that have been previ-
ously implicated in translational arrest in nonapoptotic stress
and apoptosis (Figures 3A and 3B). Since blocking mRNA
decay with DIS3L2 knockdown also inhibits apoptotic transla-
tion arrest, it is likely that mRNA decay is responsible for
most, if not all, of the translation arrest that occurs during cell
death.
How does mRNA decay promote cell death? Cell viability
under basal and stressed conditions requires mRNA expression,
as we confirmed in this study (Figure 4). In some settings, global
mRNA decay might enhance cell death by reducing specific
transcripts and their protein products. Reduced MCL-1, a pro-
tein that is rapidly degraded by the proteasome and by caspases
during apoptosis, was largely responsible for the contribution
of mRNA decay to the enhanced death of HeLa cells treated
with STS. Increased MCL-1 with DIS3L2 knockdown could
also explain whyMOMP and caspase 3 activation were reduced.
Apoptotic signaling is amplified in a feedforward loop, as cyto-(G) At 72 hr after transfection with the indicated siRNAs, cells were incubated with
by annexin V staining and flow cytometry. DIS3L2 knockdown significantly re
treatments.
(H) Cells were transfected with a plasmid expressing GFP or GFP-tagged DIS3L2
flow cytometry. Ectopic DIS3L2 expression significantly increased phosphatidyls
(I) Cells were replated at low density 48 hr after knockdown andwere treated 24 hr
cells were cultured and surviving colonies were counted. DIS3L2 knockdown s
untreated.
(J and K) siRNA-transfected cells were treated 2 days later with STS for 4 hr and p
autoradiography. A representative experiment (J) and the results of three indepen
(L) siRNA-transfected cells were treated 3 days later with STS for 4 hr and prote
(M) MCL-1 protein levels declined significantly after 4 hr of STS treatment. The d
(N) siRNA-transfected cells were treated 3 days later with STS for 3 hr and c
knockdown abolished the protective effect of DIS3L2 knockdown.
Error bars represent the SEM of at least three independent experiments. *p < 0.0
Cchrome c release leads to caspase activation, which triggers
MOMP (Arnoult et al., 2003; Lakhani et al., 2006). Feedforward
amplification is an important component of programmed cell
death. Cells loaded with exogenous cytochrome c do not
execute apoptosis without release of endogenous cytochrome
c and caspase activation (Gabriel et al., 2003). This amplification
could be attenuated by the persistence of MCL-1 in dying cells.
However, MCL-1 is not expressed in all cells, and only some cells
are sensitive to MCL-1 depletion (Petrocca et al., 2013). There-
fore, decay of the BCL2L3 transcript probably does not play an
important role in promoting death in some cell types, where
the loss of other mRNAs may be more critical. It is also possible
that mRNA might bind and inhibit apoptotic proteins, and mRNA
decay would relieve this inhibition. However, in one study (Mei
et al., 2010), tRNA (but not mRNA) inhibited apoptosome forma-
tion and caspase activation, and in another study (Thomas et al.,
2014), RNase treatment of cell lysates did not affect caspase
3 cleavage of some substrates. Nevertheless, mRNAs may influ-
ence caspase activation or specific activity in unknown ways.
Further investigation of how mRNA decay promotes apoptosis
in different settings is needed.
EXPERIMENTAL PROCEDURES
Cells
HeLa, Jurkat, HCT116, 721.221, and YT-Indy cells were obtained from ATCC.
Jurkat, YT-Indy, and 721.221 cells were grown in RPMI with 10% heat-
inactivated fetal bovine serum, 100 U/ml penicillin G, 100 mg/ml streptomycin
sulfate, 6 mM HEPES, 1.6 mM L-glutamine, and 50 mM b-mercaptoethanol.
Adherent cells were grown in DMEM with the same supplement. Stable
HeLa-puro and HeLa-BCL2 cells were generated by retroviral infection and
selection with puromycin using the pBABE-puro vector as described previ-
ously (Rajani et al., 2012).
FISH
Adherent cells were grown in 24-well plates (Corning 3524) on 12-mm glass
coverslips (VWR 89015-724) pre-treated with poly-L-lysine (Sigma P8920)
for 5 min. Jurkat cells were washed, resuspended in PBS (Life Technologies
14190-144) with 0.5% BSA (Sigma A9647) and 2 mM EDTA (Life Technologies
AM9260G), and then cytospun (Shandon Cytospin 3) for 4 min onto coverslips
at 400 rpm before fixation. YT-Indy:721.221 immune conjugates were fixed
first and then cytospun as described above. Cells were fixed for 10 min in
2% formaldehyde (Polysciences 18814) in 13 PBS and then permeabilized
in pure methanol (Fisher BP1105-4) on dry ice for 10 min. Slides were washed
three times for 5 min in 23 SSC. A control for each experiment was treated for
30 min in 0.1 M NaOH (Fisher SS255-1) in 23 SSC to hydrolyze all RNA. AllSTS or TRAIL for 3 hr or etoposide or tunicamycin for 8 hr. Cells were analyzed
duced phosphatidylserine externalization and cell survival in response to all
and treated 72 hr later, as in (G). Cells were analyzed by annexin V staining and
erine externalization in response to STS, TRAIL, and tunicamycin.
later with TRAIL or two doses of STS for 3 hr. After the drugs were removed, the
ignificantly enhanced clonogenic survival in response to all treatments. UNT,
rotein incorporation was measured by 35S incorporation followed by PAGE and
dent experiments (K) are shown. Significance relative to CTL siRNA is shown.
ins were analyzed by immunoblot.
ecline was partially rescued by DIS3L2, but not DIS3L1, knockdown.
ell death was measured by annexin V staining and flow cytometry. BCL2L3
5; **p < 0.01; ***p < 0.001. See also Figure S5.
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coverslips were inverted onto a drop of hybridization buffer (10% dextran
sulfate, 35% formamide, 0.3 M NaCl, 30 mM sodium citrate, 20 mMDTT) con-
taining 1 mM 18S rRNA probe (Cy5-ACCAGACTTGCCCTCC) and 333 nM
poly(A) (Cy3-dT50) probe. Samples were placed in a humidified chamber and
denatured for 5 min at 65C, followed by 30 min at 45C and at least 90 min
at 42C. The samples were washed three times for 5 min in 23 SSC at 37C
and stained with DAPI (Sigma D9542) in 23 SSC. Finally, the slides were
mounted using polyvinyl alcohol (Sigma P-8136) aqueous mounting medium.
Cells were imaged using an Axiovert 200M microscope (Pan Apochromat,
1.4 NA; Carl Zeiss) at 633. Images were analyzed with SlideBook 4.2 (Intelli-
gent Imaging Innovations). For quantification, cells were automatically identi-
fied based on the rRNA signal and background intensity was subtracted. All
images shown are representative of at least three independent experiments.
cRACE
Total RNA (20 mg) was treated with the DNA-free kit (Life Technologies) per the
manufacturer’s instructions. RNA was ethanol precipitated overnight and
washed twice with 70% ethanol. RNA was resuspended in 11 ml of 13 TAP
buffer (Epicenter T19050). Half of this suspension was treated with 2 U of
TAP for 1 hr at 37C, and the other half was treated the same way except
that TAP was not added. The reactions were then treated overnight at room
temperature in a 100 ml volume with 10 U of T4 RNA ligase (NEB M0204S)
with 1 mM ATP in 13 RNA ligase buffer. RNA was ethanol precipitated,
washed, and resuspended in 20 ml dH2O. Then 3 ml of this RNA was mixed
with 1 ml of 10 mM deoxyribonucleotide triphosphates (dNTPs), 2 ml of the
ACTB RT primer, and 7 ml of dH2O. This was heated to 65
C for 5 min and
cooled to 25C. Then 7 ml of a master mix containing 4 ml 53 SuperScript III
buffer, 1 ml 100 mM DTT, 1 ml SuperScript III (Life Technologies 18080-093)
and 1 ml RNaseOUT (Life Technologies 10777-019) was added. The reaction
was incubated at 55C for 60 min and 70C for 15 min before it was stored
at 4C. Then 2 ml of this reaction was mixed with 1 ml of each PCR primer
(10 mM), 6 ml dH2O, and 10 ml 23 Phusion polymerase mix (NEB M0531L),
and cycled as follows: one cycle at 98C for 30 s; 35 cycles at 98C for 10 s,
60C for 10 s, and 72C for 10 s; and one cycle at 72C for 3min. PCR products
were gel extracted and cloned using the Zero-Blunt PCR kit (Life Technologies
K2750) according to the manufacturer’s instructions. The primers used are
listed in Table S1. In the figures, line diagrams depict the mapped 50 and
30 ends; the sequence between the primers is inferred to be full-length
ACTB mRNA.
RT-PCRwith Adenylated Adaptor Primer to Detect Uridylated Decay
Products
Total RNA (1 mg) was mixed with 3 ml of a 100 mM adaptor primer and 1 ml
10 mM dNTPs in a final volume of 13 ml. This was heated to 65C for 5 min
and cooled to 25C. Then 7 ml of a master mix containing 4 ml 53 SuperScript
III buffer, 1 ml 100mMDTT, 1 ml SuperScript III, and 1 ml RNaseOUTwas added.
The reaction was incubated at 25C for 10 min, 50C for 30 min, and 70C for
15min before it was stored at 4C. Then 2 ml of this reactionwasmixedwith 1 ml
of each outer primer, 6 ml dH2O, and 10 ml 23 Phusion polymerase mix, and
cycled as follows: one cycle at 98C for 30 s; 30 cycles at 98C for 10 s,
60C for 10 s, 72C for 10 s; and one cycle at 72C for 3min. PCRwas repeated
using identical parameters with the inner primers. Products were cloned as
above. The primers used are listed in Table S1.
Plasmids
GFP reporter constructs were kindly provided by B. Glaunsinger (Abernathy
et al., 2014; Gaglia et al., 2012; Lee and Glaunsinger, 2009). GFP-DIS3L2
constructs were kindly provided by A. Dziembowski and M. Lubas (Lubas
et al., 2013).
Statistical Analysis
Pooled data from three independent cytotoxic attack FISH experiments
were compared using a Mann-Whitney test. The cRACE results obtained after
DIS3L2 knockdown were compared by Fisher’s exact test. All other p values
were computed using a two-tailed t test.
See Supplemental Experimental Procedures for additional methods.1088 Cell Reports 11, 1079–1089, May 19, 2015 ª2015 The AuthorsSUPPLEMENTAL INFORMATION
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